Evidence map›Paper›PMID 25370495›Full record

ArticlemBio2014

Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells.

Reed S Shabman, Omar J Jabado, Chad E Mire, Timothy B Stockwell, Megan Edwards, Milind Mahajan, Thomas W Geisbert, Christopher F Basler

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. NEmerging microbes & infections · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. EnterotoxigenicPathogens (Basel, Switzerland) · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Reed S Shabman
Omar J JabadoInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Chad E MireDepartment of Microbiology and Immunology, Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.
Timothy B StockwellVirology Group, J. Craig Venter Institute, Rockville, Maryland, USA.
Megan EdwardsDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Milind MahajanInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Thomas W GeisbertDepartment of Microbiology and Immunology, Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.
Christopher F BaslerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA chris.basler@mssm.edu.
Icahn School of Medicine at Mount Sinai · USThe University of Texas Medical Branch at Galveston · USJ. Craig Venter Institute · US

Funding

Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Gene Garrard Olinger · 2011 to 2026
$208.8M
Therapeutics Targeting Filoviral interferon-antagonist and replication functionsU19AI109664 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUKREYEV, ALEXANDER · 2014 to 2018
$15.8M
Molecular mechanisms of immune dysregulation by filoviral interferon U19AI109945 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2014 to 2018
$9.5M
Ebola VP35 Interferon-Antagonist: Mechanism and SignifR01AI059536 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BASLER, CHRISTOPHER F · 2005 to 2015
$4.2M
RNA Interference for the Treatment of Ebola and Marburg Hemorrhagic FeverR01AI089454 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GEISBERT, THOMAS WILLIAM, MACLACHLAN, IAN · 2010 to 2013
$2.3M
NIAID NIH HHS R01 AI059536NIAID NIH HHS R01 AI089454NIAID NIH HHS R01AI8945403NIAID NIH HHS U19 AI109664NIAID NIH HHS U19AI109664NIAID NIH HHS U19 AI109945NIAID NIH HHS U19AI109945NIAID NIH HHS UC7 AI094660
6 · The paper itself

Abstract

unlabelledDeep sequencing of RNAs produced by Zaire ebolavirus (EBOV) or the Angola strain of Marburgvirus (MARV-Ang) identified novel viral and cellular mechanisms that diversify the coding and noncoding sequences of viral mRNAs and genomic RNAs. We identified previously undescribed sites within the EBOV and MARV-Ang mRNAs where apparent cotranscriptional editing has resulted in the addition of non-template-encoded residues within the EBOV glycoprotein (GP) mRNA, the MARV-Ang nucleoprotein (NP) mRNA, and the MARV-Ang polymerase (L) mRNA, such that novel viral translation products could be produced. Further, we found that the well-characterized EBOV GP mRNA editing site is modified at a high frequency during viral genome RNA replication. Additionally, editing hot spots representing sites of apparent adenosine deaminase activity were found in the MARV-Ang NP 3'-untranslated region. These studies identify novel filovirus-host interactions and reveal production of a greater diversity of filoviral gene products than was previously appreciated. IMPORTANCE: This study identifies novel mechanisms that alter the protein coding capacities of Ebola and Marburg virus mRNAs. Therefore, filovirus gene expression is more complex and diverse than previously recognized. These observations suggest new directions in understanding the regulation of filovirus gene expression.

Indexed as

RNA EditingVirus ReplicationAnimalsCell LineChlorocebus aethiopsEbolavirusHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansMarburgvirusMolecular Sequence DataRNA, MessengerRNA, ViralSequence Analysis, DNARNA, MessengerRNA, Viral

Identifiers

PMID25370495
PMCPMC4222107
OpenAlexW2126548228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.